Fate Therapeutics
FATE
FATE
211 hedge funds and large institutions have $3.49B invested in Fate Therapeutics in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 89 increasing their positions, 64 reducing their positions, and 20 closing their positions.
Holders
211
Holders Change
+9
Holders Change %
+4.46%
% of All Funds
4.27%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.16%
New
29
Increased
89
Reduced
64
Closed
20
Calls
$6.21M
Puts
$7.44M
Net Calls
-$1.23M
Net Calls Change
-$699K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$251M |
| 2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$93.4M |
| 3 |
3
Norges Bank
Oslo,
Norway
|
$34.9M |
| 4 |
4
Fidelity Investments
Boston,
Massachusetts
|
$279M |
| 5 |
5
BlackRock
New York
|
$262M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CG
226
Cutler Group
San Francisco,
California
| – | -$44K | -1,300 | Closed |
|
|
PHK
227
Point72 Hong Kong
Hong Kong
| – | -$16K | -470 | Closed |
|
|
CAN
228
Cetera Advisor Networks
El Segundo,
California
| – | -$4K | -126 | Closed |
|
229
Lazard Asset Management
New York
| – | -$4K | -117 | Closed |
|
|
HIA
230
Harbor Investment Advisory
Lutherville,
Maryland
| – | -$1K | -41 | Closed |
|